跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,112 条关于
“HRX-233”
全部
4,112
临床试验
2,329
药物
1,400
机构
35
资讯
348
去年
HepaRegeniX Secures €21.5 Million to Advance Novel Liver Regeneration Therapy
去年
HepaRegeniX Secures €15 Million to Advance HRX-215 for Liver Regeneration
2年前
HepaRegeniX's HRX-215 Shows Promise in Liver Regeneration and Preventing Liver Failure
3年前
HepaRegeniX's HRX-0215 Shows Positive Safety Profile in Phase 1 Trial for Liver Regeneration
2年前
HepaRegenix Secures €15 Million to Advance HRX-215 Liver Regeneration Therapy
4年前
HepaRegeniX Initiates Phase 1 Trial of MKK4 Inhibitor HRX-0215 for Liver Diseases
去年
HepaRegeniX Secures €15 Million to Advance HRX-215 for Liver Regeneration
去年
Nuclear Waste from Manhattan Project Transformed into Breakthrough Cancer Treatment at Oak Ridge
27天前
New Oak Ridge Lab Accelerates Actinium-225 Supply for Next-Generation Cancer Therapies
去年
Acute Liver Failure Pipeline Shows Promise with 5+ Therapies in Development Despite Recent Setbacks
第 1 页,共 35 页
上一页
下一页